Clindamycin Phosphat Pfizer i.v./i.m. 300 mg
Clindamycin Phosphat Pfizer i.v./i.m. 300 mg is a medicine authorised by Swissmedic under authorisation number 61898. The authorisation holder is Pfizer AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 10 March 2011 and the authorisation is valid without a time limit. ATC code J01FF01 places the medicine in the group Antibacterials for systemic use.
| Authorisation number | 61898 |
|---|---|
| Name | Clindamycin Phosphat Pfizer i.v./i.m. 300 mg |
| Full name | Clindamycin Phosphat Pfizer i.v./i.m. 300 mg, Injektionslösung |
| Authorisation holder | Pfizer AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | J01FF01 |
| First authorisation | 10 March 2011 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Clindamycin Phosphat Pfizer i.v./i.m. 300 mg, Injektionslösung | A | 10 March 2011 |
| 2 | Clindamycin Phosphat Pfizer i.v./i.m. 600 mg, Injektionslösung | A | 10 March 2011 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 x 2 | ml | J01FF01 | 08.01.92 | A |
| 2 | 10 x 2 | ml | J01FF01 | 08.01.92 | A |
| 3 | 1 x 4 | ml | J01FF01 | 08.01.92 | A |
| 4 | 10 x 4 | ml | J01FF01 | 08.01.92 | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Clindamycin Phosphat Pfizer i.v./i.m. 300 mg authorised in Switzerland?
Yes. Clindamycin Phosphat Pfizer i.v./i.m. 300 mg is authorised by Swissmedic under authorisation number 61898, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Clindamycin Phosphat Pfizer i.v./i.m. 300 mg have?
Clindamycin Phosphat Pfizer i.v./i.m. 300 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Clindamycin Phosphat Pfizer i.v./i.m. 300 mg?
The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.